Profil
Robert Eberwein worked as a Director of Facilities & Engineering Operations at Catalent Maryland, Inc. from 2007 to 2017.
Prior to that, he was a Diagnostic Reagents Technologist at Becton, Dickinson & Co., Head of GMP Operations at Cambrex Corp., and a Fermentation Specialist at North American Vaccine, Inc. He received an undergraduate degree from Hood College.
Ehemalige bekannte Positionen von Robert Eberwein
| Unternehmen | Position | Ende |
|---|---|---|
Catalent Maryland, Inc.
Catalent Maryland, Inc. BiotechnologyHealth Technology Develops and manufactures biopharmaceuticals | Geschäftsführer | 01.09.2017 |
North American Vaccine, Inc.
North American Vaccine, Inc. Pharmaceuticals: OtherHealth Technology Develops and sells vaccines for the prevention of infectious diseases | Corporate Officer/Principal | - |
| BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | - |
| CAMBREX CORPORATION | Corporate Officer/Principal | - |
Ausbildung von Robert Eberwein
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Becton, Dickinson & Co.
Becton, Dickinson & Co. Medical SpecialtiesHealth Technology Manufactures and sells medical supplies, devices, laboratory equipment & diagnostic products | Health Technology |
Cambrex Corp.
Cambrex Corp. Pharmaceuticals: GenericHealth Technology Develops and manufactures drug substances | Health Technology |
North American Vaccine, Inc.
North American Vaccine, Inc. Pharmaceuticals: OtherHealth Technology Develops and sells vaccines for the prevention of infectious diseases | Health Technology |
Hood College
Hood College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Catalent Maryland, Inc.
Catalent Maryland, Inc. BiotechnologyHealth Technology Develops and manufactures biopharmaceuticals | Health Technology |
















